21st Century Cures Act — Precision Medicine Initiative — CFDA 93.368

Precision-medicine obligations at $1.24 billion

USAspending.gov records $1,244,657,073.02 in obligations under CFDA 93.368. Forty-four awards produce that stock. A simple average is about $28,287,661 per award — among the largest per-row figures in this batch and consistent with multi-year consortium funding. That average is a quotient of two packet totals, not a typical research-project budget and not a cost per participant.

The assistance-listing title is 21ST CENTURY CURES ACT - PRECISION MEDICINE INITIATIVE. CFDA 93.368 is the identifier. Other Cures Act or NIH listings tagged under different CFDA numbers are not mixed into the $1.24 billion. Combining those codes would invent a combined Cures total this packet does not contain.

33 recipients on a 21-jurisdiction map

Thirty-three recipients share 44 awards, or about 1.3 award records per recipient on average. Splitting $1,244,657,073.02 evenly would assign about $37.72 million per recipient. That density is a consortium pattern: few named organizations, large tickets. The packet does not list the 33. Recipient count is not a census of enrollment sites, biobanks, or investigators.

Twenty-one jurisdictions in the geographic count is among the tightest maps in this batch. Precision-medicine dollars still follow awarded consortium members, not equal shares. Place-of-performance amounts are on the program table.

Few awards, large tickets

Among HHS research listings, 93.368 is an extreme-concentration file: 44 rows, 33 recipients, 21 jurisdictions, about $28.3 million per award. Award count is a weak proxy for “number of precision-medicine studies” and a worse proxy for participants. Recipients (33) tell you how many named organizations sit on the extract; awards (44) tell you how many assistance rows were stored.

The packet does not report genomes sequenced, return-of-results counts, or dataset downloads. Citing 44 as studies completed or 21 as the only participating states would be a unit error. Keep the units straight: dollars, awards, recipients, jurisdictions.

Obligations versus Cures Act outlays

The $1,244,657,073.02 is an obligation total from USAspending.gov. Outlays — cash paid against Precision Medicine Initiative awards — are not in the packet. A consortium file can show a large obligation stock while annual draws follow a later calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.368 to size this Precision Medicine Initiative listing in the assistance file. Do not use it as an enrollment dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.368.

What the 93.368 tables omit

The program hub lists award-backed obligations from USAspending.gov. It is not a participant registry, not a genome catalog, and not a site directory. Series that never appear as assistance awards will not show up in the $1,244,657,073.02. That omission is definitional rather than a gap in the 44 award rows.

Place-of-performance on 21 jurisdictions is a coding field. Read the program page before treating those cells as the full enrollment map. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already paid to consortium members. A researcher comparing 93.368 with other Cures Act codes should keep CFDA numbers separate.

A researcher comparing 93.368 with other Cures Act or NIH codes should keep CFDA numbers separate. Twenty-one jurisdictions is a place-of-performance count, not the full enrollment map.

Where the 93.368 table lives

The program page overlays these four facts. The all-programs index ranks 93.368 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other HHS listings. For 93.368 only, start on the program page.

CFDA 93.368’s 44 awards spread $1,244,657,073.02 across 33 recipients and 21 jurisdictions. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 1.3 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards. Precision Medicine Initiative is a 44-row consortium book, not a nationwide formula.

The Precision Medicine Initiative is a 44-row consortium book on 33 organizations across 21 jurisdictions. About $28.3 million per award is the fingerprint, not a participant census. Read the $1,244,657,073.02 as the USAspending obligation stock for CFDA 93.368 only.

Questions

How much is obligated for the Precision Medicine Initiative?

USAspending.gov records $1,244,657,073.02 in obligations for CFDA 93.368. SpendingVault indexes 44 awards, 33 recipients, and 21 jurisdictions. The figure is an obligation sum from assistance awards, not an outlay and not a participant count. CFDA 93.368’s $1.24 billion is the USAspending obligation stock.

How many awards does CFDA 93.368 carry?

The listing shows 44 awards against 33 recipients, or about 1.3 award records per recipient. A simple average is about $28,287,661 per award. Award count is not a count of genomes or participants. Recipient dollars are on the program page.

Why does 93.368 show only 21 jurisdictions?

The extract codes awards to 21 jurisdictions in the USAspending geographic field. That is a place-of-performance count for this listing, not a statement that precision medicine exists in only 21 states. Thirty-three recipients share the $1,244,657,073.02 stock.

Is $1.24 billion already paid to precision-medicine sites?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.368’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or enrollment. The $1,244,657,073.02 on 44 awards is the obligation figure.